The public issue comprise fresh sale of shares worth Rs 580 crore besides an offer for sale of 10 lakh shares by promoter Vikram Shah, according to draft red herring prospectus (DRHP).
Proceeds of the initial public offer (IPO) will be utilised towards repayment of certain borrowings availed by the company besides purchasing medical equipment for existing, recently set-up as well as upcoming hospitals.
Also, the company plans to spend the funds for purchase of interior and infrastructure for upcoming hospitals and a portion will be kept for general corporate purposes.
Currently, the firm has a total capacity of 2,012 beds, as per Shalby's website.
More From This Section
Edelweiss Financial Services Ltd, IDFC Bank Ltd
And IIFL
Holdings Ltd are the book running lead managers to the issue.
The equity shares are proposed to be listed on the BSE and the NSE.
Earlier this month, pharmaceutical firm Eris Lifesciences had received Sebi's approval to raise an estimated Rs 2,000 crore through an IPO.